文献速递心血管US

深度学习模型用于超声心动图评估舒张功能障碍

Deep-Learning Models for the Echocardiographic Assessment of Diastolic Dysfunction.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-05-19

该研究开发了整合多维超声心动图数据的深度神经网络模型,用于识别射血分数保留的心力衰竭(HFpEF)患者中的不同亚组。模型在预测左心室充盈压升高方面优于2016年美国超声心动图学会指南分级(AUC 0.88 vs 0.67),且高危亚组与心衰住院/死亡风险增加相关,并可能从螺内酯治疗中获益。

要点

  • 深度学习模型预测左室充盈压升高的AUC为0.88,优于指南分级(0.67)。
  • 高危亚组心衰住院/死亡风险显著增高(HR 3.96),且螺内酯治疗可改善无事件生存。
  • 模型可识别HFpEF中高危患者,辅助临床风险分层和治疗决策。

局限性

  • 推导队列和验证队列样本量有限,外部验证队列较小(n=84和n=219)。
  • 研究为回顾性分析,模型在常规临床工作流中的泛化能力尚需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The authors explored a deep neural network (DeepNN) model that integrates multidimensional echocardiographic data to identify distinct patient subgroups with heart failure with preserved ejection fraction (HFpEF).

BACKGROUND: The clinical algorithms for phenotyping the severity of diastolic dysfunction in HFpEF remain imprecise.

METHODS: The authors developed a DeepNN model to predict high- and low-risk phenogroups in a derivation cohort (n = 1,242). Model performance was first validated in 2 external cohorts to identify elevated left ventricular filling pressure (n = 84) and assess its prognostic value (n = 219) in patients with varying degrees of systolic and diastolic dysfunction. In 3 National Heart, Lung, and Blood Institute-funded HFpEF trials, the clinical significance of the model was further validated by assessing the relationships of the phenogroups with adverse clinical outcomes (TOPCAT [Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function] trial, n = 518), cardiac biomarkers, and exercise parameters (NEAT-HFpEF [Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction] and RELAX-HF [Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure] pooled cohort, n = 346).

RESULTS: The DeepNN model showed higher area under the receiver-operating characteristic curve than 2016 American Society of Echocardiography guideline grades for predicting elevated left ventricular filling pressure (0.88 vs. 0.67; p = 0.01). The high-risk (vs. low-risk) phenogroup showed higher rates of heart failure hospitalization and/or death, even after adjusting for global left ventricular and atrial longitudinal strain (hazard ratio [HR]: 3.96; 95% confidence interval [CI]: 1.24 to 12.67; p = 0.021). Similarly, in the TOPCAT cohort, the high-risk (vs. low-risk) phenogroup showed higher rates of heart failure hospitalization or cardiac death (HR: 1.92; 95% CI: 1.16 to 3.22; p = 0.01) and higher event-free survival with spironolactone therapy (HR: 0.65; 95% CI: 0.46 to 0.90; p = 0.01). In the pooled RELAX-HF/NEAT-HFpEF cohort, the high-risk (vs. low-risk) phenogroup had a higher burden of chronic myocardial injury (p < 0.001), neurohormonal activation (p < 0.001), and lower exercise capacity (p = 0.001).

CONCLUSIONS: This publicly available DeepNN classifier can characterize the severity of diastolic dysfunction and identify a specific subgroup of patients with HFpEF who have elevated left ventricular filling pressures, biomarkers of myocardial injury and stress, and adverse events and those who are more likely to respond to spironolactone.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Pandey A, Kagiyama N, Yanamala N, et al. Deep-Learning Models for the Echocardiographic Assessment of Diastolic Dysfunction. JACC Cardiovasc Imaging. 2021. PMID: 34023263. doi:10.1016/j.jcmg.2021.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。